Immunostimulatory activity of CpG containing phosphorothioate oligodeoxynucleotide is modulated by modification of a single deoxynucleoside

被引:49
作者
Zhao, QY [1 ]
Yu, D [1 ]
Agrawal, S [1 ]
机构
[1] Hybridon Inc, Milford, MA 01757 USA
关键词
D O I
10.1016/S0960-894X(00)00157-8
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Phosphorothioate oligodeoxynucleotides (PS-oligos) containing the CpG motif have immunostimulatory properties. Our earlier study had shown that the immunostimulatory activity of PS-oligos containing the CpG motif can be modulated by incorporation of 2'-O-methylribonucleosides (Zhao, Q.; Yu, D.; Agrawal, S. Bioorg. Med. Chem. Lett. 1999, 9, 3453). Here we show that the immunostimulatory activity of a PS-oligo containing a CpG motif can be modulated by substitution of a single deoxynucleoside at specific sites with either 2'-O-methylribonucleoside or 3'-O-methylribonucleoside in the flanking region to CpG motif. Furthermore, substitution of deoxynucleosides with 2'-O-methoxyethoxyribonucleosides also results in modulating immunostimulatory activity of PS-oligos. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1051 / 1054
页数:4
相关论文
共 15 条
[1]   Antisense therapeutics [J].
Agrawal, S ;
Zhao, QY .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1998, 2 (04) :519-528
[2]   IMMUNE STIMULATION BY AN ANTISENSE OLIGOMER COMPLEMENTARY TO THE REV GENE OF HIV-1 [J].
BRANDA, RF ;
MOORE, AL ;
MATHEWS, L ;
MCCORMACK, JJ ;
ZON, G .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (10) :2037-2043
[3]  
Carpentier AF, 1999, CANCER RES, V59, P5429
[4]  
DUNFORD PJ, 1997, TARGETING MOL BASIS, P40
[5]   Mechanism and function of a newly identified CpG DNA moth in human primary B cells [J].
Hartmann, G ;
Krieg, AM .
JOURNAL OF IMMUNOLOGY, 2000, 164 (02) :944-952
[6]   CpG oligodeoxynucleotides do not require TH1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma [J].
Kline, JN ;
Krieg, AM ;
Waldschmidt, TJ ;
Ballas, ZK ;
Jain, V ;
Businga, TR .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 104 (06) :1258-1264
[7]  
KREIG AM, 1999, PHARMACOL THERAPEUT, V84, P113
[8]   CPG MOTIFS IN BACTERIAL-DNA TRIGGER DIRECT B-CELL ACTIVATION [J].
KRIEG, AM ;
YI, AK ;
MATSON, S ;
WALDSCHMIDT, TJ ;
BISHOP, GA ;
TEASDALE, R ;
KORETZKY, GA ;
KLINMAN, DM .
NATURE, 1995, 374 (6522) :546-549
[9]  
Macfarlane DE, 1998, J IMMUNOL, V160, P1122
[10]   Lack of immune stimulation by immobilized CpG-oligodeoxynucleotide [J].
Manzel, L ;
Macfarlane, DE .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1999, 9 (05) :459-464